Joslin Diabetes Center, Harvard School of Medicine — Boston, Massachusetts

Joslin Diabetes Center, Harvard School of Medicine is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Joslin Diabetes Center, Harvard School of Medicine has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Type 1 Diabetes (T1D).

Sponsors: Oregon Health and Science University.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Joslin Diabetes Center, Harvard School of Medicine?

Joslin Diabetes Center, Harvard School of Medicine has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Joslin Diabetes Center, Harvard School of Medicine conducted?

Joslin Diabetes Center, Harvard School of Medicine has 1 clinical trials on record, with 1 currently active. Their work covers Type 1 Diabetes (T1D).

Is Joslin Diabetes Center, Harvard School of Medicine accredited by Crixeo Health?

Joslin Diabetes Center, Harvard School of Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Joslin Diabetes Center, Harvard School of Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.